Position in ALXO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$198,162
+$103,519 QoQ
Shares Held
98,835
+18.0% QoQ
Ownership
0.073%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 68 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 99.98684676481004.ToString("F0")%
Shared 0.ToString("F0")%
None 0.01315323518996307.ToString("F0")%
Common Shares in ALXO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,423,671,747 across 511 Biotechnology names. ALXO ranks #326 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in ALXO
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $198,162 | 98,835 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $94,643 | 83,757 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $156,079 | 85,290 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $48,746 | 117,465 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $223,316 | 358,460 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,173,497 | 2,499,102 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $583,801 | 320,772 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $4,060,344 | 673,358 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $3,825,972 | 343,137 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $6,161,374 | 413,793 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $1,600,715 | 333,483 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,823,769 | 242,846 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,420,115 | 314,186 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,480,800 | 486,318 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,795,813 | 396,637 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,591,430 | 443,935 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $6,498,352 | 384,518 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $5,473,501 | 254,700 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,013,677 | 81,420 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,523,169 | 101,009 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $336,032 | 4,557 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,083,016 | 12,564 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $71,668 | 1,899 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||